Dr Gold is a consultant and performs clinical research for Stratpharma. He is also performing clinical research for Biofrontera and is a consultant to Sensus Healthcare. He has been a consultant to Dusa Pharmaceuticals and performed clinical research for them in the past.

Latest Contribution

Cellulite therapy in 2022 – new treatment options making grades for the new year

World-renowned dermatologist Michael H Gold introduces two of the newest FDA-approved modalities for the treatment of the common skin condition cellulite. Cellulite is one of the most common skin concerns for women. It is estimated that between 80-98% of women...

Higher dose neurotoxins – what’s new?

This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. How can we achieve longer lasting results with neurotoxins? With a new...

Case Study: Combination therapy with energy-based devices for improvement of facial photodamage, skin laxity and textural irregularities

Renowned dermatologist Michael Gold takes us through why combination therapies are becoming increasingly popular in facial rejuvenation. Combination therapies with energy-based devices (EBDs) have become very popular in cosmetic and aesthetic surgical circles. This applies to both the more invasive...

  • 1 (current)
  • 2
  • 3